B-hCD20 MC38
|
Common name |
B-hCD20 MC38 | Catalog number | 310716 |
| Aliases | MS4A1, Bp35, CVID5 | Disease | Colon carcinoma |
|
Organism |
Mouse |
Strain | C57BL/6 |
| Tissue types | Colon | Tissue | Colon |
Description
The human CD20 coding sequence was inserted into the ROSA26 locus in MC38 cells. Human CD20 is highly expressed on the surface of B-hCD20 MC38 cells.
Application
Gene targeting strategy for B-hCD20 MC38 cells. The exogenous promoter and human CD20 coding sequence was inserted into the ROSA26 locus in murine.
CD20 expression analysis in B-hCD20 MC38 cells by flow cytometry. Single cell suspensions from wild-type MC38 and B-hCD20 MC38 cultures were stained with species-specific anti-CD20 antibody. Human CD20 was detected on the surface of B-hCD20 MC38 cells but not wild-type MC38 cells. The 2-A12 clone of B-hCD20 MC38 cells was used for in vivo experiments.
Subcutaneous homograft tumor growth of B-hCD20 MC38 cells. B-hCD20 MC38 cells and wild-type MC38 cells were subcutaneously implanted into C57BL/6 mice (female, 8-week-old, n=5). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B) Body weight (Mean± SEM). Volume was expressed in mm3 using the formula: V=0.5 X long diameter X short diameter2. As shown in panel A, B-hCD20 MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.
The subcutaneous tumor formation of B-hCD20 MC38 cells was slow, and the inoculation dose was recommended to be increased to 1x107.
+86-010-56967680
Copyright © 2024 Biocytogen. All Rights Reserved
Powered by Fractal-technology